Sign in

CIK 0001798749

  • Emerging growth company

Jade Biosciences, Inc.

Sign in to watch
Ticker
JBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831377888
Phone
+1 781-312-3013
Business address
221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aerovate Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 84 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-27 Dake Benjamin T SEE REMARKS Sale 10b5-1 −11,068 $27.97 $310K 1,291
2024-03-27 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −11,068 29,000
2024-03-25 Dake Benjamin T SEE REMARKS Option exercise 10b5-1 +3,432 $10.61 $36K 4,723
2024-03-25 Dake Benjamin T SEE REMARKS Sale 10b5-1 −3,432 $28.01 $96K 1,291
2024-03-25 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −3,432 40,068
2024-03-19 Verwijs Marinus CHIEF TECHNICAL OFFICER Option exercise 10b5-1 +5,300 $14.59 $77K 5,300
2024-03-19 Verwijs Marinus CHIEF TECHNICAL OFFICER Sale 10b5-1 −2,536 $25.68 $65K 2,764
2024-03-19 Verwijs Marinus CHIEF TECHNICAL OFFICER Sale 10b5-1 −2,764 $26.46 $73K 0
2024-03-19 Verwijs Marinus CHIEF TECHNICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −5,300 84,700
2024-03-18 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise 10b5-1 +4,000 $1.74 $7K 7,251
2024-03-18 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise 10b5-1 +3,000 $2.14 $6K 10,251
2024-03-18 Gillies Hunter CHIEF MEDICAL OFFICER Sale 10b5-1 −6,387 $25.81 $165K 3,864
2024-03-18 Gillies Hunter CHIEF MEDICAL OFFICER Sale 10b5-1 −613 $26.40 $16K 3,251
2024-03-18 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −4,000 4,036
2024-03-18 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −3,000 98,510
2024-03-18 Dake Benjamin T SEE REMARKS Option exercise 10b5-1 +20,557 $2.14 $44K 21,848
2024-03-18 Dake Benjamin T SEE REMARKS Option exercise 10b5-1 +14,500 $10.61 $154K 36,348
2024-03-18 Dake Benjamin T SEE REMARKS Sale 10b5-1 −27,476 $25.74 $707K 8,872
2024-03-18 Dake Benjamin T SEE REMARKS Sale 10b5-1 −7,581 $26.48 $201K 1,291
2024-03-18 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −20,557 102,789

Page 6 of 16 · 315 trades